# Three-Way Time Split Training Guide

## What Is This?

The three-way time split eliminates **threshold optimization bias** by using **separate temporal data periods** for:
1. Hyperparameter tuning (Random Search + Bayesian Optimization)
2. Threshold optimization
3. Final evaluation

This prevents "double-dipping" where both hyperparameters and threshold are optimized on the same validation folds.

---

## The Problem It Solves

### Before (Two-Phase with Double-Dipping):

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚         ALL DATA (2010-2024)                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ Phase 1: Hyperparameter Tuning    â”‚    â”‚
â”‚  â”‚ CPCV â†’ Select best params          â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚              â†“                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ Phase 2: Threshold Optimization    â”‚    â”‚
â”‚  â”‚ SAME CPCV folds â† PROBLEM!        â”‚    â”‚
â”‚  â”‚ â†’ Select best threshold            â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Issue:** Both optimizations use the same validation data â†’ **5-15% optimistic bias**

---

### After (Three-Way Split):

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  TRAINING (2010-2018)                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Random Search (120 trials)              â”‚  â”‚
â”‚  â”‚ + Bayesian Opt (300 trials)             â”‚  â”‚
â”‚  â”‚ with CPCV                                â”‚  â”‚
â”‚  â”‚ â†’ Select best hyperparameters           â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                    â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  THRESHOLD (2019-2020) â† SEPARATE DATA!       â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Train model with best params from above â”‚  â”‚
â”‚  â”‚ Predict on 2019-2020 (never seen)      â”‚  â”‚
â”‚  â”‚ Optimize threshold (0.40-0.70)         â”‚  â”‚
â”‚  â”‚ â†’ Select best threshold                 â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                    â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  TEST (2021-2024) â† COMPLETELY UNTOUCHED!     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Train on 2010-2020 with best params+thrâ”‚  â”‚
â”‚  â”‚ Evaluate on 2021-2024 (never seen!)    â”‚  â”‚
â”‚  â”‚ â†’ Report TRUE OOS performance           â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Benefit:** Each optimization uses separate data â†’ **No double-dipping bias!**

---

## Quick Start

### 1. Extract Training Data

```bash
python research/extract_training_data.py \
    --symbol ES \
    --start 2010-01-01 \
    --end 2024-12-31
```

This creates: `data/training/ES_transformed_features.csv`

---

### 2. Run Three-Way Split Training

```bash
python research/train_rf_three_way_split.py \
    --symbol ES \
    --train-end 2018-12-31 \       # End of hyperparameter tuning period
    --threshold-end 2020-12-31 \   # End of threshold optimization period
    --rs-trials 120 \               # Random search trials
    --bo-trials 300 \               # Bayesian optimization trials
    --embargo-days 3                # CPCV embargo (3 days)
```

---

### 3. Review Results

The script generates:

1. **`src/models/ES_rf_model.pkl`** - Production model (trained on 2010-2020)
2. **`src/models/ES_best.json`** - Model metadata (params + threshold + training info)
3. **`src/models/ES_test_results.json`** - TRUE out-of-sample performance (2021-2024)

---

## What Happens During Each Phase

### Phase 1: Hyperparameter Tuning (2010-2018)

**Duration:** ~30-60 minutes (depends on trials)

**What it does:**
1. Loads training period data (2010-2018)
2. Performs feature screening (selects top 30 features)
3. Runs Random Search (120 trials) with CPCV
4. Runs Bayesian Optimization (300 trials) with CPCV
5. Selects best hyperparameters based on Sharpe ratio

**Example output:**
```
PHASE 1: HYPERPARAMETER TUNING (Training Period)
================================================================

Training Period:   2010-01-04 to 2018-12-31
  Trades: 8,542

Starting Random Search (120 trials)...
[RS 001/120] Sharpe=1.892 DSR=1.734 PF=1.453 Trades=2847
[RS 002/120] Sharpe=2.014 DSR=1.856 PF=1.512 Trades=2634
...
Random Search complete. Best Sharpe: 2.247

Starting Bayesian Optimization (300 trials)...
Bayesian Optimization complete. Best Sharpe: 2.312

Phase 1 Complete - Best Hyperparameters:
================================================================
Sharpe: 2.312
DSR: 2.145
Profit Factor: 1.587
Trades: 2456

Parameters: {
  "n_estimators": 900,
  "max_depth": 5,
  "min_samples_leaf": 100,
  "max_features": "sqrt",
  "bootstrap": True,
  "class_weight": "balanced_subsample",
  "max_samples": 0.8
}
```

---

### Phase 2: Threshold Optimization (2019-2020)

**Duration:** ~1 minute

**What it does:**
1. Trains model on full 2010-2018 data with best hyperparameters
2. Gets predictions on **separate** 2019-2020 data (model never saw this!)
3. Tests thresholds from 0.40 to 0.70 (31 values)
4. Selects best threshold based on Sharpe ratio

**Example output:**
```
PHASE 2: THRESHOLD OPTIMIZATION (Threshold Period)
================================================================

Threshold Period:  2019-01-02 to 2020-12-31
  Trades: 1,847

Training model on full training period (2010-2018)...
Model trained on 8,542 samples

Predicting on threshold period (2019-2020) - model has never seen this data...
Optimizing probability threshold (0.40-0.70)...

Phase 2 Complete - Best Threshold:
================================================================
Threshold: 0.55
Trades: 687
Sharpe: 1.987
Profit Factor: 1.423
Win Rate: 58.2%
```

**Key point:** Model was trained on 2010-2018, threshold optimized on **never-before-seen** 2019-2020 data!

---

### Phase 3: Final Evaluation (2021-2024)

**Duration:** ~1 minute

**What it does:**
1. Retrains model on combined 2010-2020 data (train + threshold periods)
2. Uses best hyperparameters + best threshold
3. Evaluates on **completely untouched** 2021-2024 data
4. Reports TRUE out-of-sample performance

**Example output:**
```
PHASE 3: FINAL EVALUATION (Test Period - UNTOUCHED DATA)
================================================================

Test Period: 2021-01-04 to 2024-12-31
  HELD OUT - never touched until final eval

Training production model on combined train+threshold periods (2010-2020)...
Production model trained on 10,389 samples (2010-2020)

Evaluating on test period (2021-2024) - model has NEVER seen this data...
Threshold 0.55 passes 823 / 2,145 trades

Phase 3 Complete - TRUE OUT-OF-SAMPLE PERFORMANCE:
================================================================
Test Period: 2021-01-04 to 2024-12-31
Trades: 823
Sharpe Ratio: 1.734
Sortino Ratio: 2.156
Profit Factor: 1.312
Win Rate: 56.3%
Total PnL: $142,567.50
CAGR: 18.4%
Max Drawdown: -12.3%
```

**This is your REAL performance estimate!** No peeking, no double-dipping.

---

## Command-Line Arguments

| Argument | Default | Description |
|----------|---------|-------------|
| `--symbol` | **Required** | Trading symbol (e.g., ES, NQ) |
| `--data-dir` | `data/training` | Training data directory |
| `--output-dir` | `src/models` | Output directory for models |
| `--train-end` | `2018-12-31` | End of training period (hyperparameter tuning) |
| `--threshold-end` | `2020-12-31` | End of threshold period (threshold optimization) |
| `--rs-trials` | `120` | Number of random search trials |
| `--bo-trials` | `300` | Number of Bayesian optimization trials |
| `--folds` | `5` | Number of CPCV folds |
| `--k-test` | `2` | Number of test folds in CPCV combinations |
| `--embargo-days` | `3` | Embargo days for CPCV (3 = 2-day hold + 1 buffer) |
| `--k-features` | `30` | Number of features to select |
| `--screen-method` | `importance` | Feature screening method (importance, permutation, l1, none) |
| `--seed` | `42` | Random seed for reproducibility |
| `--min-trades-threshold` | `100` | Minimum trades for valid threshold |

---

## Customizing Time Periods

You can adjust the split points based on your data availability:

### Conservative (Larger Test Set):
```bash
--train-end 2017-12-31 \      # 8 years training
--threshold-end 2019-12-31     # 2 years threshold, 5 years test
```

### Aggressive (More Training Data):
```bash
--train-end 2019-12-31 \      # 10 years training
--threshold-end 2021-12-31     # 2 years threshold, 3 years test
```

### Recommended (Balanced):
```bash
--train-end 2018-12-31 \      # 9 years training (default)
--threshold-end 2020-12-31     # 2 years threshold, 4 years test (default)
```

**Rule of thumb:**
- Training: â‰¥ 8 years (sufficient for robust optimization)
- Threshold: â‰¥ 1 year (sufficient for threshold selection)
- Test: â‰¥ 3 years (sufficient for performance evaluation)

---

## Interpreting Results

### Understanding the Three Metrics:

1. **Training Period Performance (Phase 1):**
   - **Sharpe: 2.31, DSR: 2.15**
   - This is hyperparameter selection metric (on CPCV)
   - **Optimistic** - used for choosing hyperparameters

2. **Threshold Period Performance (Phase 2):**
   - **Sharpe: 1.99**
   - This is threshold selection metric (on 2019-2020 holdout)
   - **More realistic** - threshold uses separate data

3. **Test Period Performance (Phase 3):**
   - **Sharpe: 1.73**
   - This is TRUE out-of-sample performance (on 2021-2024)
   - **Most realistic** - completely untouched data
   - **THIS IS YOUR REAL EXPECTED PERFORMANCE!**

### Typical Pattern:

```
Training Sharpe > Threshold Sharpe > Test Sharpe
    2.31      >      1.99       >     1.73
```

**Why decreases are normal:**
- Training: Optimized for this data â†’ naturally highest
- Threshold: Separate data â†’ slight degradation
- Test: Completely new data â†’ further degradation

**What to watch for:**
- âœ… **Good:** Test Sharpe within ~20% of training (e.g., 2.3 â†’ 1.8)
- âš ï¸ **Concerning:** Test Sharpe drops >40% (e.g., 2.3 â†’ 1.3) â†’ overfitting
- ðŸš¨ **Bad:** Test Sharpe negative while training positive â†’ severe overfitting

---

## Comparison: Old vs New Approach

| Aspect | Old (Double-Dipping) | New (Three-Way Split) |
|--------|----------------------|-----------------------|
| **Hyperparameter data** | 2010-2024 CPCV | 2010-2018 CPCV |
| **Threshold data** | Same CPCV folds | 2019-2020 holdout |
| **Final test** | Not done | 2021-2024 (never touched) |
| **Reported Sharpe** | 2.1 (optimistic) | 1.7-1.9 (realistic) |
| **Bias estimate** | +15% optimistic | ~0% (unbiased) |
| **Training time** | ~45 min | ~50 min (+10%) |
| **Data efficiency** | Uses 100% for training | Uses 60% train, 15% threshold, 25% test |

---

## FAQ

### Q: Why is the test Sharpe lower than training Sharpe?

**A:** This is **normal and expected!** The training Sharpe is optimized for that specific data. The test Sharpe shows true generalization. A 15-25% decrease is typical and healthy.

---

### Q: Can I use more recent data for testing?

**A:** Yes! Adjust `--threshold-end` forward:
```bash
--threshold-end 2022-12-31  # Test on 2023-2024 only
```

Just ensure you have â‰¥3 years of test data for robust evaluation.

---

### Q: What if I don't have data back to 2010?

**A:** Adjust dates proportionally. Example with 10 years (2014-2024):
```bash
--train-end 2020-12-31 \      # 7 years training
--threshold-end 2022-12-31     # 2 years threshold, 2 years test
```

---

### Q: Can I skip Bayesian optimization to save time?

**A:** Yes:
```bash
--bo-trials 0  # Only random search
```

This reduces runtime from ~45 min to ~15 min, but may sacrifice ~0.1-0.2 Sharpe points.

---

### Q: How do I deploy the trained model?

**A:** The script saves:
- `ES_rf_model.pkl` - Load this in production
- `ES_best.json` - Contains threshold and features

Copy to production directory:
```bash
cp src/models/ES_* /path/to/production/models/
```

---

## Troubleshooting

### "Insufficient training data"

**Error:**
```
ValueError: Symbol ES has only 1,234 trades, need at least 500 for training
```

**Solution:** Extract more data or use longer time period:
```bash
python research/extract_training_data.py --symbol ES --start 2005-01-01 --end 2024-12-31
```

---

### "No trades in threshold period"

**Warning:**
```
Threshold Period: 0 trades
```

**Solution:** Check if symbol was actively traded during 2019-2020. Adjust `--threshold-end`:
```bash
--threshold-end 2021-12-31  # Use 2019-2021 for threshold
```

---

### "Test Sharpe is negative"

**Issue:** Model failed to generalize.

**Possible causes:**
1. Overfitting to training period
2. Market regime change between train/test
3. Insufficient training data

**Solutions:**
- Reduce model complexity: `--k-features 20` (fewer features)
- Increase embargo: `--embargo-days 5` (more purging)
- Review training vs test periods for regime changes

---

## Next Steps

1. **Run the script** on your primary symbols (ES, NQ, etc.)
2. **Review test results** in `*_test_results.json`
3. **Compare** old approach vs three-way split performance
4. **Deploy** if test Sharpe meets your requirements (e.g., >1.5)
5. **Monitor** live performance and compare to test Sharpe

---

## Technical Notes

### Key Differences from `rf_cpcv_random_then_bo.py`:

1. **Temporal data split** - Not random/fold-based
2. **Threshold on separate data** - Not same CPCV folds
3. **Final test set** - Completely untouched until Phase 3
4. **Three output files** - Model, metadata, AND test results
5. **Unbiased performance** - Test Sharpe is true OOS estimate

### What Stays the Same:

- âœ“ Random Search (120 trials)
- âœ“ Bayesian Optimization (300 trials with Optuna)
- âœ“ Random Forest classifier
- âœ“ CPCV within training period
- âœ“ Feature screening
- âœ“ All same hyperparameters
- âœ“ Same DSR multiple testing correction

**Bottom line:** Same optimization methods, different data usage = no bias!

---

## References

- LÃ³pez de Prado, M. (2018). "Advances in Financial Machine Learning"
  - Chapter 7: Cross-Validation in Finance
  - Chapter 11: The Dangers of Backtesting
- Bailey, D. H., & LÃ³pez de Prado, M. (2014). "The Deflated Sharpe Ratio"

---

**Status:** âœ… Ready for production use
**Created:** 2025-10-30
**Author:** Claude (Anthropic)
